These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7977646)

  • 1. Presence of immunoreactive corticotropin releasing hormone in thyroid lesions.
    Scopa CD; Mastorakos G; Friedman TC; Melachrinou M; Merino MJ; Chrousos GP
    Am J Pathol; 1994 Nov; 145(5):1159-67. PubMed ID: 7977646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary.
    Mastorakos G; Webster EL; Friedman TC; Chrousos GP
    J Clin Invest; 1993 Aug; 92(2):961-8. PubMed ID: 8394389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries.
    Mastorakos G; Scopa CD; Vryonidou A; Friedman TC; Kattis D; Phenekos C; Merino MJ; Chrousos GP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1191-7. PubMed ID: 7525629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
    Johnson TL; Lloyd RV; Thor A
    Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
    Abu-Alfa AK; Straus FH; Montag AG
    Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of immunoreactive corticotropin-releasing hormone in human endometrium.
    Mastorakos G; Scopa CD; Kao LC; Vryonidou A; Friedman TC; Kattis D; Phenekos C; Rabin D; Chrousos GP
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1046-50. PubMed ID: 8772574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents.
    Mastorakos G; Bouzas EA; Silver PB; Sartani G; Friedman TC; Chan CC; Caspi RR; Chrousos GP
    Endocrinology; 1995 Oct; 136(10):4650-8. PubMed ID: 7664685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
    Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
    Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
    Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
    Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of the grooved nucleus in thyroid lesions.
    Scopa CD; Melachrinou M; Saradopoulou C; Merino MJ
    Mod Pathol; 1993 Nov; 6(6):691-4. PubMed ID: 8302810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of basement membrane laminin distribution in nonneoplastic and neoplastic thyroid tissue.
    Campo E; Perez M; Charonis AA; Axiotis CA; Merino MJ
    Mod Pathol; 1992 Sep; 5(5):540-6. PubMed ID: 1344818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?
    Unger P; Ewart M; Wang BY; Gan L; Kohtz DS; Burstein DE
    Hum Pathol; 2003 Aug; 34(8):764-9. PubMed ID: 14506636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
    Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
    Nasser SM; Pitman MB; Pilch BZ; Faquin WC
    Cancer; 2000 Oct; 90(5):307-11. PubMed ID: 11038428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
    Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin: a differentiation marker in thyroid malignancies.
    Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
    Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid.
    Aydin O; Yildiz L; Kefeli M; Kandemir B
    Pathol Res Pract; 2008; 204(6):359-65. PubMed ID: 18337018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
    J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.